Comparing etoricoxib and celecoxib for preemptive analgesia for acute postoperative pain in patients undergoing arthroscopic anterior cruciate ligament reconstruction: a randomized controlled trial

Tanarat Boonriong, Boonsin Tangtrakulwanich, Prapakorn Glabglay, Sasikaan Nimmaanrat, Tanarat Boonriong, Boonsin Tangtrakulwanich, Prapakorn Glabglay, Sasikaan Nimmaanrat

Abstract

Background: The efficacy of selective cox-2 inhibitors in postoperative pain reduction were usually compared with conventional non-selective conventional NSAIDs or other types of medicine. Previous studies also used selective cox-2 inhibitors as single postoperative dose, in continued mode, or in combination with other modalities. The purpose of this study was to compare analgesic efficacy of single preoperative administration of etoricoxib versus celecoxib for post-operative pain relief after arthroscopic anterior cruciate ligament reconstruction.

Methods: One hundred and two patients diagnosed as anterior cruciate ligament injury were randomized into 3 groups using opaque envelope. Both patients and surgeon were blinded to the allocation. All of the patients were operated by one orthopaedic surgeon under regional anesthesia. Each group was given either etoricoxib 120 mg., celecoxib 400 mg., or placebo 1 hour prior to operative incision. Post-operative pain intensity, time to first dose of analgesic requirement and numbers of analgesic used for pain control and adverse events were recorded periodically to 48 hours after surgery. We analyzed the data according to intention to treat principle.

Results: Among 102 patients, 35 were in etoricoxib, 35 in celecoxib and 32 in placebo group. The mean age of the patients was 30 years and most of the injury came from sports injury. There were no significant differences in all demographic characteristics among groups. The etoricoxib group had significantly less pain intensity than the other two groups at recovery room and up to 8 hours period but no significance difference in all other evaluation point, while celecoxib showed no significantly difference from placebo at any time points. The time to first dose of analgesic medication, amount of analgesic used, patient's satisfaction with pain control and incidence of adverse events were also no significantly difference among three groups.

Conclusions: Etoricoxib is more effective than celecoxib and placebo for using as preemptive analgesia for acute postoperative pain control in patients underwent arthroscopic anterior cruciate ligament reconstruction.

Trial registration number: NCT01017380.

Figures

Figure 1
Figure 1
Pain Intensity among each group during 48 hour after surgery.

References

    1. Sinatra R. Role of COX-2 inhibitors in the evolution of acute pain management. J Pain Symptom Manage. 2002;24(1 Suppl):S18–27. doi: 10.1016/S0885-3924(02)00410-4.
    1. White PF. The changing role of non-opioid analgesic techniques in the management of postoperative pain. Anesth Analg. 2005;101:S5–22. doi: 10.1213/01.ANE.0000177099.28914.A7.
    1. Michaloliakou C, Chung F, Sharma S. Preoperative multimodal analgesia facilitates recovery after ambulatory laparoscopic cholecystectomy. Anesth Analg. 1996;82:44–51. doi: 10.1097/00000539-199601000-00009.
    1. Ilan DI, Liporace FA, Rosen J, Cannavo D. Efficy of rofecoxib for pain control after knee arthroscopy: a prospective, randomized, double-blinded clinical trial. Arthroscopy. 2004;20:813–8.
    1. Ekman EF, Wahba M, Ancona F. Analgesic efficacy of perioperative celecoxib in ambulatory arthroscopic knee surgery: a double-blind, placebo control study. Arthroscopy. 2006;22:635–42. doi: 10.1016/j.arthro.2006.03.012.
    1. White PF. The role of non-opiod analgesic techniques in the management of pain after ambulatory surgery. Anesth Analg. 2002;94:577–85. doi: 10.1097/00000539-200203000-00019.
    1. Puura A, Puolakka P, Rorarius M, Salmelin R, Lindgren L. Etoricoxib pre-medication for post-operative pain after laparoscopic cholecystectomy. Acta Anaesthesiol Scand. 2006;50:688–93. doi: 10.1111/j.1399-6576.2006.01049.x.
    1. Vane JR, Botting RM. New insights into the mode of action of anti-inflammatory drugs. Inflamm Res. 1995;44:1–10. doi: 10.1007/BF01630479.
    1. Schafer AI. Effects of nonsteriodal anti-inflammatory drugs on platelet function and systematic hemostasis. J Clin Pharmacol. 1995;35:209–19.
    1. Stitchtenoth DO, Frolich JC. The second generation of COX-2 inhibitors: what advantages do the newest offer? Drugs. 2003;63:33–45. doi: 10.2165/00003495-200363010-00003.
    1. Chang DJ, Desjardins PJ, King TR, Erb T, Geba GP. The analgesic efficacy of etoricoxib compared with oxycodone/acetaminophen in acute postoperative pain model: a randomized, double blind clinical trial. Anesth Analg. 2004;99:807–15. doi: 10.1213/01.ANE.0000133141.75831.57.
    1. Kim JT, Sherman O, Cuff G, Leibovits A, Wajda M, Bekker AY. A double- blind prospective comparison of rofecoxib vs ketorolac in reducing postoperative pain after arthroscopic knee surgery. J Clin Anesth. 2005;17:439–43. doi: 10.1016/j.jclinane.2004.09.008.
    1. Desjardins PJ, Grossman EH, Kuss ME, Talwalker S, Dhadda S, Baum D, Hubbard RC. The injectable cyclooxygenase-2-inhibitor parecoxib sodium has analgesic efficacy when administered preoperatively. Anesth Analg. 2001;93:721–7. doi: 10.1097/00000539-200109000-00036.
    1. Tang J, Li S, White PF, Chen X, Wender RH, Quon R, Sloninsky A. et al.Effect of parecoxib, a novel intravenous cyclooxygenase type -2 inhibitor, on the postoperative opioid requirement and quality of pain control. Anesthesiology. 2002;96:1305–9. doi: 10.1097/00000542-200206000-00007.
    1. Chan VW, Clark AJ, Davis JC, Wolf RS, Kellstein D, Jayawardene S. The post-operative analgesic efficacy and tolerability of lumiracoxib compared with placebo and naproxen after total knee or hip arthroplasty. Acta Anaesthesiol Scand. 2005;49:1491–500. doi: 10.1111/j.1399-6576.2005.00782.x.
    1. Kellstein D, Ott D, Jayawardene S, Fricke J. Analgesic efficacy of a single dose of lumiracoxib compared with rofecoxib, celecoxib and placebo in the treatment of postoperative dental pain. Int J Clin Pract. 2004;58:244–50. doi: 10.1111/j.1368-5031.2004.00155.x.
    1. Rassmussen GL, Malmstrom K, Bourne MH, Jove M, Rhondeau SM, Kotey P. et al.Etoricoxib provides analgesic efficacy to patients after knee or hip replacement surgery: a randomized, double-blind, placebo-controlled study. Anesth Analg. 2005;101:1104–11. doi: 10.1213/01.ane.0000169294.41210.9e.
    1. Buvanendran A, Kroin JS, Tuman KJ. et al.Effects of perioperative administration of a selective cyclooxygenase 2 inhibitor on pain management and recovery of function after knee replacement: a randomized controlled trial. JAMA. 2003;290:2411–8. doi: 10.1001/jama.290.18.2411.
    1. Clarke R, Derry S, Moore RA, McQuay HJ. Single dose oral etoricoxib for acute postoperative pain in adults. Cochrane Database of Systematic Reviews. 2009. p. CD004309.
    1. Derry S, Barden J, McQuay HJ, Moore RA. Single dose oral celecoxib for acute postoperative pain in adults. Cochrane Database of Systematic Reviews. 2008. p. CD004233.
    1. Recart A, Issioui T, White PF, Klein K, Watcha MF, Stool L, Shah M. The efficacy of celecoxib premedication on postoperative pain and recovery times after ambulatory surgery: a dose-ranging study. Anesth Analg. 2003;96:1631–5.
    1. Issioui T, Klein K, White PF, Watcha MF, Coloma M, Skrivanek G. et al.The efficacy of premedication with celecoxib and acetaminophen in preventing pain after otolaryngologic surgery. Anesth Analg. 2002;94:1188–93. doi: 10.1097/00000539-200205000-00025.
    1. Bingham C III, Sebba A, Rubin B, Ruoff G, Kremer J, Bird S. et al.Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies. Rheumatology. 2007;46:496–507. doi: 10.1093/rheumatology/kel296.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren